Award
Delivery Order #SPE2DR26FP1XY
AmerisourceBergen Awarded Delivery Order for Mesalamine Tablets
Buyer
Defense Logistics Agency
Award Amount
$1,576.98
Ceiling
$1,576.98
Awarded
February 13, 2026
Period of Performance
Feb 13, 2026 – Feb 17, 2026
Identifier
SPE2DR26FP1XY
NAICS
424210
This award represents a delivery order contract issued under a broader indefinite delivery/indefinite quantity (IDV) agreement with AmerisourceBergen Drug Corp, a prominent global pharmaceutical sourcing and distribution company. The contract specifically procures Mesalamine 1.2 gm tablets, a pharmaceutical product essential for medical treatments. The significance of this award lies in supporting continued access to vital medications, thereby reinforcing healthcare delivery and public health outcomes. The scope of work includes the timely supply and distribution of Mesalamine tablets, fulfilling a short-term need within a defined period. The contract was awarded through existing IDV arrangements, streamlining procurement efficiency. The performance period is a multi-day term scheduled for early 2026 at a facility based in Conshohocken, Pennsylvania. This delivery order complements the parent contract aimed at ensuring a steady supply of essential pharmaceuticals from late 2025 through 2026, continuing AmerisourceBergen's critical role in supporting federal healthcare programs.
Description
4570831549!MESALAMINE DR 1.2 GM TABLET 120S